Cambridge, UK, Techbio company Qureight has appointed Dr Steven Bishop to the role of Chief Data Officer (CDO). This significant cornerstone addition to the senior leadership team further evidences Qureight’s commitment to scientific rigour and data quality.
Dr Bishop, who brings extensive experience of solving healthcare challenges with machine learning and data science, is now responsible for ensuring that Qureight’s AI and imaging biomarker models are trained on the best quality data. He will also take charge of maintaining and extending Qureight’s global network of data relationships, which spans NHS Trusts, hospital groups, contract research organisations and industry.
Dr Bishop is a Cambridge University trained computer scientist and a medical doctor, specialising in anaesthetics and intensive care medicine as an Academic Clinical Fellow and Speciality Registrar at Cambridge University Hospital NHS Foundation Trust. His former leadership roles include a stint as Director of Clinical, Regulatory and AI at digital physiotherapy clinic Flok Health and several years heading up the data analytics and AI strategy at leading medical device company CMR Surgical.
Qureight’s digital infrastructure houses and curates multiple types of medical data for powerful analysis and biomarker development. The company has ongoing strategic collaborations and research partnerships with some of the most well-known healthcare, research and pharmaceutical companies in the world, including AstraZeneca, Vicore Pharma, and several NHS Trusts.
In April, Qureight announced a $8.5m Series A raise to accelerate the development of their AI-driven product portfolio and expand into new diseases including lung cancer.
Dr Steven Bishop, Chief Data Officer at Qureight, said:
“Qureight is operating right at the frontier of AI’s application to improve population health. This makes it a hugely exciting place to be, as the opportunities for global scaling and impact are almost unlimited.
“Within the company, there is a really strong commitment to maintaining the robust scientific foundation of their work. As a data scientist and a medic, this principle is extremely important to me and was one of the primary motives behind my decision to join the team.
“An ample supply of high quality and diverse training data is essential for the building of AI and imaging biomarkers that are accurate and generalisable. As Chief Data Officer, I look forward to building upon Qureight’s existing network of collaborators and partners, while continuing to enhance our governance processes that ensure patient data is used in an ethical, compliant and secure fashion.”
Dr Muhunthan Thillai, founder and CEO of Qureight, said:
“Data is the core of everything we do at Qureight, and as such, our Chief Data Officer holds a pivotal position in the company. Steven’s academic and professional background is extremely well-suited to the role, and we’re extremely pleased to be welcoming him into the team.
“This new appointment will help to accelerate and advance our work with hospitals, clinical research organisations and multinational pharmaceutical companies to find new treatments for complex lung and heart disease.”